NASDAQ NMS - GLOBAL MARKET · INMD
-0.59% · -$0.0900 · Vol 498.7K
Market closed · last close 4:00 PM ET · price as of 16:00:34 ET
Inmode Ltd

Inmode Ltd

Health Care
$15.12
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
INMD
Inmode Ltd
Thu Aug 6 · last completed session · Markets closed · resumes Fri 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

65/ 100
Veridion Score
BUY BIAS · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Thu Aug 6 · last completed session · Markets closed · resumes Fri 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is INMD moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading INMD catalysts
About Inmode Ltd
Health Care
Listed since
2019
Employees
660
Country
IL

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$15.24
Day high
$15.29
Day low
$15.06
Previous close
$15.21
52W high
$16.62
-9.03% from high
52W low
$12.76
61% of range
Market cap
$874.3M
P/E
9.97×
EPS
$1.36
Beta
0.40
Shares out
57.5M
Volume
498.7K
0.76× rel vol
Avg volume
653K
VWAP
$15.12
Price history computed in-house
1W
-0.13%
1M
+4.56%
3M
+8.31%
1Y
+5.22%
YTD
+2.93%
SMA 50 $14.48 · above
SMA 200 $14.36 · above
52W position 61%

INMD overview

Veridion Score
65
5 of 6 factors measured
Congress receipts
2
Tom Rice · Sale
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around INMD.Congress disclosuresOpen receipt and filing context for INMD.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading INMD Form 4 filings
Public disclosures

Congress activity in INMD

Congress trackerOpen ticker disclosure ledger →
Federal contracts

INMD contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for INMD in this window.
Lobbying spend

INMD lobbying filings, year to date.

Registered lobbying filings matched to Inmode Ltd.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for INMD in this window.
Loading news for INMD
Analyst ratings
Sovereign unlock shows live analyst consensus for INMD.
Options
Sovereign unlock shows live options positioning for INMD.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.